Sign Up Today and Learn More About NRG Therapeutics Stock
Invest in or calculate the value of your shares in NRG Therapeutics or other pre-IPO companies through EquityZen's platform.
NRG Therapeutics Stock
NRG Therapeutics is a drug discovery company focussed on therapeutic approaches that will restore mitochondrial function.
About NRG Therapeutics Stock
Founded
2018
Industries
Travel and Tourism, Manufacturing, Space
NRG Therapeutics Press Mentions
Stay in the know about the latest news on NRG Therapeutics
Santhera Closes USD 13 Million Royalty Monetization Agreement
globenewswire • Nov 05, 2025
Parkinson’s disease: biotech’s pursuit for more therapies
labiotech • Oct 31, 2025
NRG Therapeutics expands senior team with newly-created roles
businessweekly • Oct 27, 2025
Isaac Health partners with LillyDirect to broaden Alzheimer’s specialist care access
longevity • Oct 25, 2025
NRG Therapeutics recruits senior leadership to drive NRG5051 clinical launch
longevity • Oct 25, 2025
NRG Therapeutics Management
Leadership team at NRG Therapeutics
Board of Director
Charlotte Kremers
Board of Directors
Emma Johnson
Join now and verify your accreditation status to gain access to:
- NRG Therapeutics Current Valuation
- NRG Therapeutics Stock Price
- NRG Therapeutics Management
- Available deals in NRG Therapeutics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- NRG Therapeutics Cap Table and Funding History by Share Class and Liquidity Preferences
- NRG Therapeutics Revenue and Financials
- NRG Therapeutics Highlights
- NRG Therapeutics Business Model
- NRG Therapeutics Risk Factors
- NRG Therapeutics Research Report from SACRA Research
Trading NRG Therapeutics Stock
How to invest in NRG Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like NRG Therapeutics through EquityZen funds. These investments are made available by existing NRG Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell NRG Therapeutics stock?
Shareholders can sell their NRG Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 400K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 49K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."